Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03950921 · ClinicalTrials.gov registry record · NA

Pilot Testing a Patient Safety Display in the Hospital Setting

A NA study of Pressure Injury and Catheter-Related Infections, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
132
Enrollment target
1
Study location

NCT03950921: Completed NA study of Pressure Injury and Catheter-Related Infections, sponsored by University of Michigan.

NCT03950921 is a NA study of Pressure Injury and Catheter-Related Infections that has completed, run by University of Michigan. The registered enrollment target is 132 participants, below the 1,144-participant average among 6 other Pressure Injury trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03950921, a NA study of Pressure Injury and Catheter-Related Infections, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
132 participants
Enrollment target
1
Study location

Study Summary

This is a feasibility pilot study to introduce and evaluate an intervention designed to increase clinician awareness of their patients' urinary catheters, vascular catheters, and pressure injuries. This intervention, the "Patient Safety Display" will be evaluated in one hospital unit.

Primary Outcome

Proportion of physicians and advanced practice providers aware of their patients' indwelling urinary catheters; measured via survey

Interventions

  • BEHAVIORAL Patient Safety Display

Study Locations (1)

Michigan

  • University Hospital, Michigan Medicine - Ann Arbor

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2019-06-24
Est. Completion 2019-09-20
Phase NA
University of Michigan

1,327 total trials

What the finished NCT03950921 record still lists

NCT03950921 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,144-participant average among 6 other Pressure Injury trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Pressure Injury appearing as the primary indexed condition, and to 1 intervention - of which Patient Safety Display is the first listed.

NCT03950921 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT03950921 about?

NCT03950921 is a clinical study titled "Pilot Testing a Patient Safety Display in the Hospital Setting". This is a feasibility pilot study to introduce and evaluate an intervention designed to increase clinician awareness of their patients' urinary catheters, vascular catheters, and pressure injuries. This intervention, the "Patient Safety Display" will be evaluated in one hospital unit.

What is the current status of trial NCT03950921?

This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2019-06-24. Estimated completion is 2019-09-20.

What conditions does trial NCT03950921 study?

This clinical trial studies the following conditions: Pressure Injury, Catheter-Related Infections.

What interventions are being tested in trial NCT03950921?

The interventions under investigation include: Patient Safety Display (BEHAVIORAL).

Who is sponsoring clinical trial NCT03950921?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03950921 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pressure Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01766297 · 132 participants · Phase 2

    Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

  • NCT04002947 · 132 participants · Phase 2

    Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

  • NCT04128189 · 132 participants · Phase 3

    Shingrix in Renal Transplant Recipients

  • NCT04199780 · 132 participants · NA

    Effects of tDCS Combined With CBI on Postsurgical Pain

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03950921, the US trial registry maintained by the National Library of Medicine. NCT03950921 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.